A detailed history of Jane Street Group, LLC transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 23,754 shares of LIFE stock, worth $44,182. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,754
Previous 28,456 16.52%
Holding current value
$44,182
Previous $44,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.51 - $2.24 $7,100 - $10,532
-4,702 Reduced 16.52%
23,754 $44,000
Q2 2024

Aug 14, 2024

SELL
$0.0 - $2.07 $0 - $69,725
-33,684 Reduced 54.21%
28,456 $44,000
Q1 2024

May 15, 2024

BUY
$1.42 - $2.02 $88,238 - $125,522
62,140 New
62,140 $121,000
Q2 2022

Aug 16, 2022

SELL
$2.63 - $5.61 $333,336 - $711,033
-126,744 Reduced 92.58%
10,157 $29,000
Q3 2021

Nov 16, 2021

BUY
$4.22 - $12.48 $577,722 - $1.71 Million
136,901 New
136,901 $1.24 Million

Others Institutions Holding LIFE

About aTYR PHARMA INC


  • Ticker LIFE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,625,000
  • Market Cap $53.2M
  • Description
  • aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...
More about LIFE
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.